Histologics Announces Kylon® Fabric Review Published in Advances in Skin & Wound Care

Histologics, LLC Announces Publication of Comprehensive Review in Advances in Skin & Wound Care Highlighting Impact of Kylon® Fabric

ANAHEIM, CA, UNITED STATES, November 10, 2026 /EINPresswire.com/ — Histologics, LLC, a medical device company advancing compassionate tissue sampling and wound care solutions, today announced publication of a clinical review in the peer-reviewed journal, Advances in Skin & Wound Care. The article, titled “Advancing Chronic Wound Healing: Innovations in Hooked-Array Kylon^® Fabric for Wound Hygiene, Debridement, and Tissue Sampling” details the clinical evolution, proven efficacy, and applicability of Histologics’ proprietary hooked nylon fabric (Kylon^®) technology in chronic wound management.

Chronic wounds, affecting approximately 6.5 million individuals annually in the United States, present a mounting healthcare challenge. These non-healing wounds are difficult to treat due to persistent inflammation, poor circulation, and bacterial biofilms—protective microscopic matrices that harbor harmful pathogens and are found in up to 90% of chronic wounds. Traditional methods of addressing these barriers, such as sharp surgical excision or enzymatic treatments, are often underutilized due to patient discomfort, the need for specialized provider training, and time or cost constraints.

The newly published review, authored by wound care experts including Traci Kimball, MD, MBA, CWSP, Laura Swoboda, DNP, APNP, CWOCN-AP, Frank Aviles, PT, CWS, and Histologics Founder and CEO Neal Lonky, MD, MPH, highlights how hooked-array nylon fabric offers a minimally invasive, effective alternative that overcomes gaps in care.

From Gynecology to Advanced Wound Care: The Evolution of Kylon^®

Originally developed for gynecological procedures as a patient-friendly alternative to sharp metal cervical biopsy instruments, Histologics’ hooked nylon fabric (Kylon^®) has been adapted for advanced wound care. The medical-grade fabric is composed of sickle-shaped, stiff nylon hooks woven into a flexible base. When applied to tissue with controlled pressure and frictional motion, these microscopic hooks flatten into precise micro-curettes.

This mechanical action allows clinicians to perform systematic, incremental tissue removal. The fabric atraumatically excises necrotic tissue, surface exudates, and devitalized slough without sharp cutting blades. Crucially, excised tissue and disrupted biofilm are trapped within the hook array for safe disposal or laboratory transport, minimizing cross-contamination.

“The transition of our Kylon^® medical fabric from gynecological diagnostics to chronic wound care represents a paradigm shift in tissue management,” said Dr. Neal Lonky, Founder and CEO of Histologics, LLC. “This publication validates what we have observed in clinical practice: our technology provides caregivers with an affordable, gentle, precise tool to overcome fundamental barriers to wound healing. By addressing biofilm and devitalized tissue without the collateral damage or pain associated with traditional sharp instruments, we are empowering clinicians and patients.”

Unlocking the Healing Cascade: Clinical and Immunological Benefits

The peer-reviewed paper details several key therapeutic mechanisms by which the hooked nylon fabric enhances chronic wound healing:

▪️ Targeted Biofilm Disruption and Wound Hygiene: By providing friction-based, mechanical debridement, the fabric thoroughly disrupts entrenched biofilms. Its use is highly compatible with evidence-based wound hygiene protocols, serving as an effective “paint brush” cleaning method during routine dressing changes when used without applied pressure.

▪️ Precision Debridement and Tissue Preservation: When pressurized, the sickle-hooks penetrate the wound base to precisely remove necrotic tissue while
preserving the underlying, viable healing tissue. This atraumatic approach ensures optimal wound bed preparation.

▪️ Immunological Modulation and Angiogenesis: The micro-trauma induced by the frictional debridement stimulates localized immune responses. This action triggers micro-punctate bleeding and whole blood clot formation, which are essential for increasing vascularization and perpetuating the proliferative phase of healing.

▪️ Diagnostic Tissue Sampling: The device excels in capturing true-tangential biopsy samples from the wound base. By trapping intact tissue fragments and organisms within its matrix, it provides superior specimens for conventional culture or molecular testing compared to standard swabbing techniques,
ensuring accurate pathogen identification.

▪️ Optimizing Advanced Therapies: Beyond primary debridement, the precise wound bed preparation achieved with the hooked nylon fabric maximizes the efficacy of advanced therapies. By creating a thoroughly cleansed, micro-perforated wound base with pinpoint bleeding, the technology facilitates superior adherence and bioavailability of cellular tissue products and bioengineered skin substitutes.

Expanding Access Across Diverse Clinical Settings

One advantage highlighted in the review is the technology’s accessibility. The single-use, sterile, and cost-effective nature of Histologics’ fabric-based devices makes them valuable across a wide spectrum of care environments. From high-acuity surgical centers and outpatient wound clinics to resource-limited home health settings, caregivers of varying skill levels can safely perform wound hygiene and debridement.

Furthermore, the atraumatic procedure often eliminates the need for general anesthesia or costly operating room time, allowing complex debridement and biopsies to be performed under local anesthesia at the bedside. The technology also eliminates sharps disposal containers, further streamlining clinical logistics.

As healthcare systems increasingly focus on value-based care, technologies that reduce patient morbidity, prevent costly hospital readmissions, and accelerate the healing of chronic wounds are essential. The integration of Histologics’ Kylon^® fabric into standard wound care protocols promises to not only enhance clinical outcomes but also significantly reduce the global economic burden associated with chronic wound management.

For more information about Histologics, LLC and its innovative Kylon^® medical fabric technology, please visit www.histologics.com.

About Kylon^® and Histologics, LLC

Histologics is a medical device company with a mission to compassionately save lives, and is dedicated to advancing gentle, effective tissue management solutions for women’s health, advanced wound care, and veterinary medicine. Its proprietary, patented, and award-winning Kylon^® technology platform is a hooked brush array medical fabric that can safely and compassionately be used to precisely and gently remove tissue from the body for diagnostics and therapeutic tissue removal of diseased tissue. Histologics provides clinicians with innovative cost-effective tools that enhance procedural efficiency, accuracy, and patient comfort. Histologics products have been adopted by leading academic, government, HMO, hospitals, private practice settings, and home settings
nationwide.

A compendium of research and clinical evidence over the last 15 years can be found at: https://www.histologics.com

Lily Ramos
Histologics, LLC
+1 888-235-2275
Visit us on social media:
LinkedIn
Instagram
Facebook
TikTok
X

Media gallery

About The Author

Written By: EIN Presswire